Press release University of Dundee Drug Discovery Unit licenses USP15 assets to Corbin Therapeutics The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS). Published on 5 June 2019